People who have severe gastrointestinal conditions like inflammatory bowel disease (IBD) or gastroparesis should not go on GLP-1s, and neither should people with a personal or family history of multiple endocrine neoplasia 2A, multiple endocrine neoplasia 2B, medullary thyroid cancer, or pancreatitis
So, if we can improve our kidneys ability to excrete excess sodium, manage fluid balance, and reduce vessel stiffening, well likely see improvements in blood pressure
Its ability to stimulate tissue repair while maintaining immune balance makes it a candidate for supporting chronic gut conditions such as ulcerative colitis (UC)
Notably, tirzepatide exhibits superior glycemic and weight reduction efficacy compared with traditional GLP-1RAs, with both classes conferring cardiovascular protection
Jayn is a Brand Ambassador for Skinny Bottle and is our preferred choice